In this study, we demonstrate the prognostic impact of CD226, as evaluated by flow cytometry using freshly extracted, noncultured CD8+ TILs from liver metastasis of CRC, which guaranteed the accuracy of the expression data for the studied biomarkers. This evidence concerns the gene CD226 and colorectal carcinoma.